Total income stood at Rs 396 crore for the June quarter against Rs 303 crore in the year-ago period, AstraZeneca Pharma India said in a reg...

The facility currently occupies 334,000 square feet of office space at Ramanujan IT City, with plans to add approximately 180,000 square fe...

AstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca w...

British-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...

The primary endpoint was overall survival (OS) for the combination versus sorafenib and secondary endpoints included OS for durvalumab vers...

Marwaha has been instrumental in building strategic frameworks for the company in India in tandem with the evolving environment of the phar...

Drug firm AstraZeneca India on Friday said it has received approval from the domestic drug regulator to market a drug to treat biliary trac...

State Bank of India said its board has approved Rs 10,000 crore capital raising plan through Tier I bonds. The fund raising through Additio...

Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asi...

Bankers say early 155 million cards went out of the market because of the EMV migration from magnetic-strip to chip-based cards, weeded out...

Panchal was posted at Mahidpur Halka in the district and has been under the scanner of Lokayukta police for last three months.